Antibodies: Monoclonal and Polyclonal and their Differences

Antibodies: Monoclonal and Polyclonal and their Differences

Post Views: 7,200 In the study and treatment of infectious diseases such as Covid-19 and Human Immunodeficiency Virus or HIV, one frequently hears the term “antibodies”. Antibodies are protein elements produced by the immune system. They fortify the human body’s defence mechanism to combat bacterial, viral diseases, or antigens and obstruct them from affecting human…

Antibody therapies for the prevention and treatment of viral infections

Antibody therapies for the prevention and treatment of viral infections

Post Views: 1,361 The recent and still ongoing pandemic of Covid-19 shook the world in ways unimaginable. Labs worldwide were urged to find therapies to prevent and treat this deadly viral infection. Today one often hears the word ‘antibodies’ mentioned during this disease’s treatment and recovery phase. But, What are antibodies? What are the antibody…

Monoclonal Antibody Therapy for COVID-19

Monoclonal Antibody Therapy for COVID-19

Post Views: 771 Monoclonal antibodies are laboratory-created proteins that replicate the immune system’s capacity to combat diseases such as SARS-CoV-2. Furthermore, SARS-CoV-2, like other infectious organisms, can change over time, resulting in specific therapies failing to act against particular variations, such as the Omicron. Monoclonal antibodies are medicinal agents being researched to treat COVID-19. These…

Does a Covid infection guarantee protective antibodies?

Does a Covid infection guarantee protective antibodies?

Post Views: 1,032 Among the most extraordinary questions of the overwhelming COVID-19 pandemic is the toughness of resistance and time to likely reinfection. There is restricted direct information on SARS-CoV-2 long-term immune responses and reinfection. Antibodies are essential for the body’s immune response to infection. Antibodies that neutralise SARS-CoV-2, which causes COVID-19, are typically recognisable…

Neutralizing Antibodies for the COVID-19 treatment

Neutralizing Antibodies for the COVID-19 treatment

Post Views: 1,390 The severe acute respiratory syndrome, also known as SARS-CoV-2 or the Covid-19 has caused unusual global health and economic dilemmas. Numerous vaccine strategies and repurposed drugs are currently under evaluation for safety and efficiency. Meanwhile, diverse neutralizing monoclonal antibodies (nMAbs) targeting SARS-CoV-2 spike glycoprotein are in diverging stages of clinical trials and…